AI Healthcare Market Growth — 38.6% Annual CAGR

At a compound annual growth rate of approximately 38.6%, the AI healthcare market is expanding roughly five times faster than the overall health-tech category and substantially faster than global healthcare spending as a whole.

A CAGR at this level rarely sustains beyond a ten-year window. Historical analogs from adjacent tech categories — cloud-infrastructure market growth in the early 2010s, mobile-health in the mid 2010s — showed similar early trajectories before flattening into single-digit maturity growth.

What likely drives continued high growth through 2028–2030: FDA device tracker acceleration (295 new authorizations in 2025 alone), pharma AI-platform adoption at scale (enabled by foundation-model advances in structural biology and generative chemistry), and regulatory clarity improving for software-as-a-medical-device (SaMD).

What could compress the CAGR: reimbursement policy (AI CPT codes remain limited and vary by payer), clinical-evidence requirements tightening as regulators respond to early deployment data, and consolidation reducing the number of distinct revenue-generating vendors.

For strategic planning: do not assume 38.6% CAGR will persist as the decade closes. Model growth at declining rates from 2028 forward, with sensitivity to regulatory and reimbursement outcomes.